CARISOPRODOL COMPOUND

Pre-Launch

aspirin; carisoprodol

ANDAORALTABLET

Lifecycle

Pre-Launch

Data completeness

1/8 — Limited

CARISOPRODOL COMPOUND (aspirin; carisoprodol) by Teva is clinical pharmacology carisoprodol: carisoprodol is a centrally-acting muscle relaxant that does not directly relax tense skeletal muscles in man.

Drug data last refreshed 1mo ago

Mechanism of Action

CLINICAL PHARMACOLOGY Carisoprodol: Carisoprodol is a centrally-acting muscle relaxant that does not directly relax tense skeletal muscles in man. The mode of action of carisoprodol in relieving acute muscle spasm of local origin has not been clearly identified, but may be related to its sedative…

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Worked on CARISOPRODOL COMPOUND at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.